IDO1 and head and neck squamous cell carcinoma: The objective of this study was therefore to evaluate the expression of IDO and IL4I1 in a tissue microarray of HNSCC patients to assess a functional and prognostic role and to discover the dynamic immune landscape within HNSCC.